Planning and evaluation activities have played a key role in the growth and steady improvement of KUCC. Multiple internal committees including KUCC Leadership Council and Associate Directors Council guide the planning and evaluation process under the leadership of Director Jensen and in coordination with the External Advisory Board (EAB). The EAB serves a critical role in providing external oversight of planning and evaluation of KUCC vision, direction, leadership, research programs, and supporting infrastructure. The EAB was selected by KUCC leadership to match our research programs, shared resources and administrative components. The EAB has made numerous major recommendations such as defining the relationship between the KU Hospital and KUCC, increasing the number of patients on therapeutic trials, suggesting a timeline for the PSO application, suggesting ways to tighten membership criteria, expanding the number of NCI funded investigators, better integrating with the Stowers Institute for Medical Research, integrating clinicians into the Drug Discovery, Delivery and Experimental Therapeutics Program, and improving the KUCC website. KUCC Leadership Council promotes scientific interactions between the basic, translational, and clinical elements of the Center, plans development of the research programs, leverages KUCC resources for maximum benefit, and oversees activities of KUCC programs. The Associate Directors Council evaluates cross-program activities including symposia, seminars and conferences, allocations of pre-and post-doctoral trainee stipends and KUCC pilot research grants, and new research membership applications as well as conducts an annual review of membership. Each year the Associate Directors Council reviews the progress of the research programs, shared resources and administrative functions of KUCC. The KUCC-ADC makes final recommendations to the Director on practically all issues including budget, resource allocation, membership, space, leadership appointments, and strategic direction. The MCA Partners Advisory Board promotes collaboration of key hospitals and research institutions in the areas of research and education and advises the Cancer Center Director on the impact of KUCC in the community.

Public Health Relevance

Planning and evaluation activities have clearly been an essential component of our continued and steady improvement over the last seven years and will continue to play a critical role in the future. KUCC's External Advisory Board and key internal advisory groups have played important roles in this activity and this has resulted in a vigorous and robust process of envisioning our potential, thoughtful reflection, and proactive change management.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA168524-03
Application #
8702104
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2014-07-01
Budget End
2015-06-30
Support Year
3
Fiscal Year
2014
Total Cost
$20,532
Indirect Cost
Name
University of Kansas
Department
Type
DUNS #
016060860
City
Kansas City
State
KS
Country
United States
Zip Code
66160
Walker, Logan C; Marquart, Louise; Pearson, John F et al. (2017) Evaluation of copy-number variants as modifiers of breast and ovarian cancer risk for BRCA1 pathogenic variant carriers. Eur J Hum Genet 25:432-438
Lal, Shruti; Cheung, Edwin C; Zarei, Mahsa et al. (2017) CRISPR Knockout of the HuR Gene Causes a Xenograft Lethal Phenotype. Mol Cancer Res 15:696-707
Xiao, Lifu; Tian, Xiumei; Harihar, Sitaram et al. (2017) Gd2O3-doped silica @ Au nanoparticles for in vitro imaging cancer biomarkers using surface-enhanced Raman scattering. Spectrochim Acta A Mol Biomol Spectrosc 181:218-225
Pessetto, Ziyan Y; Chen, Bin; Alturkmani, Hani et al. (2017) In silico and in vitro drug screening identifies new therapeutic approaches for Ewing sarcoma. Oncotarget 8:4079-4095
Wolfe, Andy R; Ernlund, Amanda; McGuinness, William et al. (2017) Suppression of intestinal tumorigenesis in Apc mutant mice upon Musashi-1 deletion. J Cell Sci 130:805-813
Sasaki, Ken; Kurahara, Hiroshi; Young, Eric D et al. (2017) Genome-wide in vivo RNAi screen identifies ITIH5 as a metastasis suppressor in pancreatic cancer. Clin Exp Metastasis 34:229-239
New, Jacob; Arnold, Levi; Ananth, Megha et al. (2017) Secretory Autophagy in Cancer-Associated Fibroblasts Promotes Head and Neck Cancer Progression and Offers a Novel Therapeutic Target. Cancer Res 77:6679-6691
Brinker, Amanda E; Vivian, Carolyn J; Koestler, Devin C et al. (2017) Mitochondrial Haplotype Alters Mammary Cancer Tumorigenicity and Metastasis in an Oncogenic Driver-Dependent Manner. Cancer Res 77:6941-6949
Do, Thuy-Vy; Hirst, Jeff; Hyter, Stephen et al. (2017) Aurora A kinase regulates non-homologous end-joining and poly(ADP-ribose) polymerase function in ovarian carcinoma cells. Oncotarget 8:50376-50392
Spaw, Mark; Anant, Shrikant; Thomas, Sufi Mary (2017) Stromal contributions to the carcinogenic process. Mol Carcinog 56:1199-1213

Showing the most recent 10 out of 135 publications